(23 days)
The Bone Graft Syringe is intended for use as a piston syringe for aspiration of bone marrow, autologous blood, plasma, or other body fluids. The syringe can be used to mix bone graft materials with aspirated fluids and deliver the composite graft material to the orthopedic surgical site.
Additional sizes of the previously cleared Bone Graft Syringe (510(k): K023088) are being added to the current product offering. The syringe can be used for withdrawing body fluids and re-injecting the fluids and/or composite graft materials into the body.
The provided document is a 510(k) summary for the Bone Graft Syringe (K062173). It focuses on establishing substantial equivalence to a previously cleared predicate device, rather than presenting a study demonstrating AI device performance against specific acceptance criteria.
Therefore, many of the requested sections (e.g., acceptance criteria, reported device performance, sample sizes for test sets, expert involvement, MRMC study, standalone performance, training set details) are not applicable or not provided in this type of document.
The document primarily states that the intended use, materials, and design features of the Bone Graft Syringe are the same as the predicate devices. This implies that the device meets its "acceptance criteria" by being substantially equivalent to devices already proven safe and effective.
Here's a breakdown of the requested information based on the provided document:
1. A table of acceptance criteria and the reported device performance
- Acceptance Criteria: Not explicitly stated as quantifiable performance metrics for AI. The implicit acceptance criterion is "substantial equivalence" to the predicate device in terms of intended use, materials, and design.
- Reported Device Performance: Not provided as measurable performance data. The document states, "The safety and effectiveness of the Bone Graft Syringe is adequately supported by the substantial equivalence information provided within the Premarket Notification."
2. Sample size used for the test set and the data provenance
- Not applicable. This document describes a medical device (syringe), not an AI algorithm requiring a test set for performance evaluation.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Not applicable. Ground truth establishment by experts for an AI test set is not relevant to this device submission.
4. Adjudication method for the test set
- Not applicable. No test set or adjudication method is described.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- No. This is a syringe, not an AI device, so an MRMC study is not relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- No. This is a physical device, not an algorithm.
7. The type of ground truth used
- Not applicable. No ground truth for an AI algorithm is referenced. The "truth" in this context is that the device is substantially equivalent to legally marketed predicate devices.
8. The sample size for the training set
- Not applicable. No training set for an AI algorithm is referenced.
9. How the ground truth for the training set was established
- Not applicable. No training set or ground truth establishment for it is referenced.
{0}------------------------------------------------
AUG 23 2006
K062173
Image /page/0/Picture/1 description: The image shows the word "WRIGHT." in a bold, sans-serif font. Below the word is a graphic of three horizontal lines that are angled downwards and slightly overlap each other. The lines appear to be thicker on the left side and taper off towards the right. There is a small "TM" symbol in the bottom right corner of the graphic.
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe m accordance with and 1990 and in conformance with 21 CRF 807, this information serves as a Summary of Safety and Effectiveness for the use of the Bone Graft Syringe.
| Submitted By: | Wright Medical Technology, Inc. |
|---|---|
| Date: | July 27, 2006 |
| Contact Person: | Wesley L. Reed |
| Regulatory Affairs Specialist II | |
| Proprietary Name: | Bone Graft Syringe |
| Common Name: | Piston Syringe |
| Classification Name and Reference: | 21 CFR 880.5860 Piston syringe - Class II |
| Device Product Code and Panel Code: | FMF/General Hospital-80 |
DEVICE INFORMATION
A. INTENDED USE
The Bone Graft Syringe is intended for use as a piston syringe for aspiration of bone marrow, autologous blood, plasma, or other body fluids. The syringe can be used to mix bone graft materials with aspirated fluids and deliver the composite graft material to the orthopedic surgical site.
B. DEVICE DESCRIPTION
Additional sizes of the previously cleared Bone Graft Syringe (510(k): K023088) are being added to the current product offering. The syringe can be used for withdrawing body fluids and re-injecting the fluids and/or composite graft materials into the body.
C. SUBSTANTIAL EQUIVALENCE INFORMATION
The intended use, materials, and design features of the Bone Graft Syringe are the same as the predicate devices previously cleared for market. The safety and effectiveness of the Bone Graft Syringe is adequately supported by the substantial equivalence information provided within the Premarket Notification.
5677 Airline Road Arlinaton TN 38007
971 phone
international subsidiaries 011.32.2.378.3905 Belgium 011.39.0250.678.227 ftalv
905.826.1600 Canada
011 33 1 45 13 24 40 France
011.49.4161.745130 Germany
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus symbol.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 3 2006
Wright Medical Technology, Inc. % Mr. Wesley L. Reed Regulatory Affairs Specialist II 5677 Airline Road Arlington, Tennessee 38002
Re: K062173
Trade/Device Name: Bone Graft Syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston syringe Regulatory Class: II Product Code: FMF Dated: July 27, 2006 Received: June 31, 2006
Dear Mr. Reed:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{2}------------------------------------------------
Page 2 - Mr. Wesley L. Reed
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
for Pato Mz
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Kob2473
Indications for Use
510(k) Number (if known):
Device Name: Bone Graft Syringe
Indications For Use:
The Bone Graft Syringe is intended for use as a piston syringe for aspiration of bone w marrow, autologous blood, plasma, or other body fluids. The syringe can be used to mix bone graft materials with aspirated fluids and deliver the composite graft material to the orthopedic surgical site.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
1 of 1
(Division Sign-Division of General, Restorative and Neurological Devices
510(k) Number /K062173
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).